Published October 24, 2026
Morning Report — Not Your Typical Medical Newsletter
We get it, you see a lot of medical newsletters, so hear us out. Once a month, we’ll highlight important medical news sprinkled with witty commentary, fun facts, giveaways, and more… because learning should be fun! Subscribe to receive the Morning Report directly.
Good morning! It’s Nobel season, so let’s revisit Werner Forssmann, a past winner who took research into his own hands—and veins. In 1929, the 25-year-old German surgical resident proposed an experiment to his supervisor: Could a catheter safely reach a living human heart? Permission denied. So, Forssmann numbed his own arm, threaded a urinary catheter roughly 65 cm up a vein, and walked to radiology for an x-ray revealing the tip in his right atrium.
Two dismissals and a career change later, Forssmann shared the Nobel Prize—27 years after the experiment, while practicing as a small-town urologist.
Speaking of bold ideas, this month the 2026 Nobel Prize in Physiology or Medicine honored Karl Deisseroth, Peter Hegemann, and Georg Nagel for their work on optogenetics, which lets scientists switch nerve cells on or off with light. Impressive, but did they try it on themselves?
ACOG Issues First Menopause Guideline Update Since 2014
WOMEN’S WELLNESS WATCH
Some clinicians who studied ACOG’s last menopause guidelines in training are now reading the update for personal reasons. It’s been 12 years. ACOG’s most comprehensive menopause guidance yet expands recommendations for an unwelcome mix of symptoms, with more detail on hormone therapy and a wider range of nonhormonal options.
The grades are in
ACOG—clearly not a superstitious group—released Clinical Practice Guideline No. 13 earlier this month with graded treatment options for hot flashes, sleep disruption, and mood symptoms. “Recommends” means most informed patients would choose the treatment; “suggests” means the trade-offs leave more room for individual preferences. Here’s where things landed:
- Recommends: Systemic menopausal hormone therapy (MHT) to tame hot flashes, night sweats, and related sleep disruption in eligible patients. For those who cannot or prefer not to use hormones, SSRIs/SNRIs may help ease vasomotor symptoms and depression; neurokinin antagonists (fezolinetant and elinzanetant) target vasomotor symptoms and related sleep disruption.
- Suggests: Gabapentin for vasomotor symptoms when other recommended nonhormonal drugs are ineffective or poorly tolerated; cognitive behavioral therapy, mindfulness, exercise, clinical hypnosis, and acupuncture for selected symptoms.
- Doesn’t support: Phytoestrogens and herbal supplements.
Don’t call it a comeback
Hormone therapy has baggage. Recovering from the 2002 breast cancer headlines has taken decades of research—and a Martha Stewart–level reputation overhaul. The risks haven’t disappeared, but researchers have clarified that the benefit–risk balance depends on the regimen, timing, and patient history. ACOG’s advice: Weigh symptom relief against breast cancer, cardiovascular, and clotting risks.
Key takeaways
Ask directly about hot flashes, sleep, and mood. When patients choose MHT and have no contraindications, ACOG recommends starting before age 60 or within 10 years of natural menopause, usually with a progestogen if the uterus is intact. Individualize when to stop. Follow drug-specific liver monitoring requirements for neurokinin antagonists and treat diagnosed depression according to depression guidelines. Black cohosh gummies? Skip.
For more education on menopause, check out this CME activity: The Menopause Reset: Recognizing Symptoms and Rethinking Hormones
Short Sprints vs Long Rides on a Molecular Scale
METABOLIC MINUTE
Chet wanted to “cruise in comfort” on a pontoon boat. Roman wanted to “skim the waves” in a jet boat. Decades after The Great Outdoors, researchers have taken that boating dispute to the gym: A long, moderate ride or short bursts at full throttle? The speed sessions stirred up a much larger immediate molecular response. Somewhere, Roman is taking credit.
Fast and furious vs slow and steady
Researchers compared two cycling protocols in 19 young, healthy, active men: six 30-second, all-out sprints with four-minute rests, or 90 minutes of moderate cycling. They tracked circulating blood proteins, some of which relay messages between muscle, fat, liver, and other tissues and may contribute to exercise’s metabolic benefits. Immediately afterward, all-out cycling changed levels of nearly 25% of measured proteins; moderate cycling altered <0.25%. Same digits, very different decimal placement. By three hours, moderate cycling boosted fatty acids and liver-derived proteins involved in the endurance response. Retesting after eight weeks of training showed similar patterns. Researchers then cross-referenced exercise-responsive proteins with UK Biobank health data. Of 33 proteins they identified as linked to lower metabolic disease risk, sprinting changed levels of 32; moderate exercise, only three.
Pump the breaks
The small, healthy, all-male cycling sample limits generalizability. Half the population remains a follow-up question. The workouts also differed in both intensity and duration, making their separate effects hard to untangle. And a busier bloodstream isn’t automatically a healthier one: Disease-risk links came from a separate observational study. These molecular changes don’t prove that sprints prevent disease or beat moderate exercise over time.
Key takeaways
This study sketches a biological explanation for why brief, intense exercise may help, and it opens a conversation with patients pressed for time. The sprints totaled only three minutes, but four-minute rests between sprints complicated an otherwise excellent headline. The findings don’t establish a new exercise prescription or warrant retiring moderate activity. Exercise discussions still need to weigh patients’ health, fitness, preferences, and willingness to repeat the experience. A dazzling molecular shift loses appeal if “all out” leads to “never again.” For patients uninterested in cycling, other brief, vigorous activities might produce similar molecular effects. Further studies will have to determine whether the stationary bike holds exclusive rights.
For more education on physical activity, check out this CME activity: Movement Matters—Is There an Optimal Exercise Routine for Treating Hypertension?
Not All That Burns Is a UTI
INFECTIOUS FINDINGS
A booming voice, billowing smoke, an enormous floating head—Oz fooled most. Then Toto pulled back the curtain. Burning, urgency, and frequency can make an equally convincing impression of a UTI. But researchers peeked behind the symptoms and found that things aren’t always as they seem.
UTI diagnosis—it’s complicated
In a retrospective chart review, researchers dug into the medical records of 253 women evaluated at a specialty clinic for recurrent UTIs and persistent urogenital symptoms despite negative urine cultures. The persistent symptoms called for a broader explanation: Only 15% of the women had problems confined to the bladder or urinary tract. Researchers found signs consistent with hormonally mediated vestibulodynia—pain at the vaginal entrance—in 85% and pelvic floor hypertonicity—overly tight muscles—in 75%, with overlap between groups. Both conditions can mimic a UTI or accompany an infection.
A few leaks
Medical charts keep records; they don’t settle cause and effect. This retrospective review can’t establish which conditions caused the symptoms, and a specialty-clinic population doesn’t represent every woman with recurrent UTIs. The findings also don’t erase a history of infection: Infection and its mimics can share a patient.
Key takeaways
“Another UTI” deserves more than another prescription. Obtain urinalysis and urine cultures before treating symptomatic recurrent episodes, and investigate persistent symptoms when cultures no longer support infection. Examine the vulvar tissue and pelvic floor, review medications and hormonal changes, and consider vaginal estrogen for eligible perimenopausal and postmenopausal patients with recurrent UTIs. As urologist Maria Uloko puts it, assess the “pelvic ecosystem as a whole.”
For more education on UTIs, check out this CME podcast: UTI Guidelines for Primary Care: What’s New in Diagnosis, Treatment, and Prevention?
Interested in more healthcare news? Here are some other articles we don’t want you to miss:
- GLP-1s tied to detached fingernails in new study
- Selective serotonin reuptake inhibitors and immune checkpoint blockade in solid tumors: A target trial emulation with pan-cancer transcriptomic analyses
- Noninvasive test accurately diagnoses, quantifies amyloid
- Taste dysfunction in long COVID
- Alzheimer’s decline slows with just a few thousand steps a day
Morning Report is written by:
- Alissa Scott, Author
- Aylin Madore, MD, MEd, Editor
- Margaret Oliverio, MD, Editor
- Ariel Reinish, MD, MEd, Editor
- Emily Ruge, Editor
Did You Enjoy This Issue of Morning Report?
Absolutely! | For the most part | Not at all
Click above, or share your feedback via email. Drop us an email at morningreport@pri-med.com to let us know how we’re doing.
Please note that the summaries in Morning Report are intended to provide clinicians with a brief overview of an article, and while we do our best to select the most salient points, we ask that you please read the full article linked in each summary for clarification before making any practice-changing decisions.
Enjoying Morning Report? Share It with Colleagues!
Is Morning Report for you? It is if you’re someone who needs quick-hitting, accurate medical news—but with some flair.
You don’t just need to know about the latest metabolism study—you also need to know how it parallels an Alanis Morissette hit. If you’re reading about acupuncture treatment, you need us to skip the needle puns and get straight to the point. We keep things simple, but when we do get into the scientific weeds, we always remind you to check for ticks.
Subscribe to receive Morning Report directly in your inbox the first Saturday of every month.